Search results
Showing 571 to 585 of 753 results for adult social
improving oral health and reducing oral health inequalities among groups of adults at high risk of poor oral health? Any explanatory...
Mogamulizumab for previously treated T-cell leukaemia-lymphoma [ID1390]
Discontinued Reference number: GID-TA10464
Evidence-based recommendations on quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care.
Relugolix–estradiol–norethisterone for treating symptoms of endometriosis (TA1057)
Evidence-based recommendations on relugolix–estradiol–norethisterone (Ryeqo) for treating symptoms of endometriosis in adults of reproductive age.
Show all sections
NG98/3 Question Use of hearing aids and incidence of dementia:- In adults with hearing loss, does the use of hearing aids reduce the...
Evidence-based recommendations on bempedoic acid with ezetimibe (Nilemdo and Nustendi) for treating primary hypercholesterolaemia or mixed dyslipidaemia as an adjunct to diet in adults.
interventions for depression and anxiety disorders in adults with mild to moderate learning disabilities:- For adults with...
Source guidance details Comes from guidance Social work with adults experiencing complex needs Number NG216 Date issued
systems and processes are effective and cost effective in changing health and social care practitioners' decision-making and ensuring...
details Comes from guidance Advocacy services for adults with health and social care needs Number NG227 Date issued November
Diabetes mellitus type 1 and type 2: insulin glargine biosimilar (Abasaglar) (ESNM64)
Summary of the evidence on insulin glargine biosimilar (Abasaglar) for type 1 and type 2 diabetes mellitus to inform local NHS planning and decision-making
circumstances and the risk of dependence: Do individual circumstances such as social distress, low income or limited access to...
Dupilumab for treating moderate to severe atopic dermatitis (TA534)
Evidence-based recommendations on dupilumab (Dupixent) for treating moderate to severe atopic dermatitis in adults.
Brodalumab for treating moderate to severe plaque psoriasis (TA511)
Evidence-based recommendations on brodalumab (Kyntheum) for treating moderate to severe plaque psoriasis in adults.
activities. People with MS who have cognitive problems often engage in fewer social and vocational activities, are less likely to be in...